CSR’s primary role is to handle the receipt and review of all grant applications that NIH receives. NIH separates the review process from funding decisions.
For Reviewers
Reviewers are critical to our mission to see that NIH grant applications receive, fair, independent, expert, and timely scientific reviews. We appreciate the generosity with which reviewers give their time.
Study Sections
Applications are reviewed in study sections (Scientific Review Groups, SRGs). Review Branches (RBs) are clusters of study sections based on scientific discipline.
Review Meetings
Applications are reviewed in study sections (Scientific Review Groups, SRGs). Review Branches (RBs) are clusters of study sections based on scientific discipline.
Evaluation Initiatives
Access data visualizations, reports, and analytical tools to track progress.
About CSR
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.
The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit
cc.nih.gov.
Updates regarding government operating status and resumption of normal operations can be found at
OPM.gov.
Dr. Emily Kilroy earned her Ph.D. in occupational science with a concentration in neuroscience from the University of Southern California (USC). She also holds a Master of Science from University College London and Yale University, specializing in developmental neuropathology. Dr. Kilroy has…
Dr. Gloria Su received her Ph.D. in immunology from the University of Chicago. Her post-doctoral training at the Johns Hopkins University School of Medicine focused on identifying tumor suppressor genes and oncogenes important to pancreatic tumorigenesis. She joined the faculty of the Johns Hopkins…
Dr. Ian Thorpe received his Ph.D. from The Scripps Research Institute (California) in the field of computational biochemistry and biophysics, where he was a trainee of the La Jolla Interfaces in Science program. He then did postdoctoral training in the Center for Biophysical Modeling and Simulation…
Dr. Ramos-Lopez holds a Ph.D. in biochemistry and molecular biology from the Universidad Complutense of Madrid, Spain. She completed her doctoral studies on the development of vaccines against leishmaniasis in a canine model. Then, she pursued postdoctoral training at the Icahn School of Medicine…
Dr. Jennifer Fiori O’Connell received her Ph.D. in Cell and Molecular Biology from the University of Pennsylvania School of Medicine investigating the dysregulation of bone morphogenetic protein signaling pathways in Fibrodysplasia Ossificans Progressiva (FOP), a devastating genetic condition in…
Dr. Juraj Bies received his Ph.D. in cancer genetics from the Scientific Council for Molecular Biology and Genetics, Slovak Academy of Sciences and Comenius University in Bratislava, Slovakia. He did his postdoctoral training in the field of viral oncogenesis at NIH in the Laboratory of Genetics…
Dr. Khalida Shamim earned her Ph.D. in synthetic organic chemistry from Indiana University, Bloomington, where she focused on the total synthesis of natural products and published her research on stemona alkaloids as well as the quinone methide macrolide, kendomycin. She subsequently joined…
Dr. Bogdanov obtained his Ph.D. in biomedical sciences in 1999 at the Graduate School of Biomedical Sciences, Mount Sinai School of Medicine / City University of New York, where he studied molecular and cellular mechanisms that contribute to vessel reocclusion following coronary angioplasty. After…
Dr. Jui Pandhare received her Ph.D. in biochemistry from the National Chemical Laboratory, Pune, India. Her thesis research was focused on functional characterization of microbial protease inhibitors for agricultural and industrial use. She then moved to the National Cancer Institute/NIH as a…
Dr. Laurent Taupenot’s academic background includes a B.S in biochemistry, cellular biology and physiology and a M.S in physiology from the University of Burgundy in Dijon, France, an advanced degree (DEA) in molecular and cellular biology and a Ph.D. in cellular and molecular neurobiology, both…
Dr. Shree Ram Singh received his Ph.D. in genetics from the Banaras Hindu University, India, and was a scientist at Goethe University Frankfurt, Germany. After postdoctoral training at Haifa University, Israel, and at the National Cancer Institute (NCI), he became a staff scientist at NCI. He has…
Before coming to CSR, Dr. Shivakumar Chittari worked at the Henry M. Jackson foundation supporting the NIH Uniformed Services University (USU) Precision Medicine Program as Director for Administration and Research Projects. In addition, he provided scientific peer review support for the USU Vice…
Most competing grant applications to NIH require electronic submission using the SF424 (R&R) application forms. Electronic submission involves two separate systems working together – the federal portal Grants.gov and the NIH eRA Commons. The Office of Extramural Research provides information on…
Dr. Anna Babakhanyan received a master’s degree in biotechnology from San Jose State University and her Ph.D. in tropical medicine from the University of Hawaiʻi School of Medicine. She evaluated naturally acquired antibody responses to pregnancy-associated malaria vaccine candidates in Cameroonian…
Dr. Tang-Toth received her Ph.D. degree from Johns Hopkins University and did her postdoctoral training as an IRTA fellow within the Cell Biology and Metabolism Program at the NIH National Institute of Child Health and Human Development. Prior to joining CSR, Dr. Tang-Toth was an associate…
Dr. Kumud Singh serves as Chief of the Immunology and Infectious Diseases A Review Branch (IIDA RB).Dr. Kumud K. Singh earned his Ph.D. in biophysics at the University of Delhi, India, where he studied the structure-functional properties of catalytic RNAs. His postdoctoral research at the…
Using the ECR Application and Vetting System (EAVS) you can enroll or update your information. ECRs remain in the program until they no longer meet the criteria. For example, if you have been accepted into the program but receive an R01, you will be removed from our database of ECRs even if you…
Dr. Abu Abdullah is a behavioral scientist, public health physician and global health researcher with a Ph.D. in Community Medicine and an M.P.H. in Epidemiology. Before joining CSR, Dr. Abdullah was an associate professor of medicine at Boston University School of Medicine and Boston University…
Ms. Lynch leads the center’s ethics program. She oversees a staff of ethics professionals who are the first line of contact for employees. Ms. Lynch works with both employees and supervisors to ensure employee compliance with ethics rules, regulations, and policies, and the prevention or…
Mark D. Lindner, PhD, is currently serving as Acting Branch Chief of the Analysis, Informatics, and Automation (AIA) Branch within the Division of Planning, Analysis, and Information Management (DPAIM) at CSR—a role he assumed in August 2023 following seven years as leader of the Office of Planning…
Open the folder where you saved the zApps file. Figure 1 shows the folders and files included in the zApps. Double-click on the file ClickMe.htm, which will open in your default web browser (but you do not need to be connected to the Internet to open this file).
Figure 1- List of files…
Prior to the meeting, reviewers are assigned to your application.Your scientific review officer (SRO) is your main contact while your application is under peer review. The SRO will analyze the content of your application, check for completeness and compliance with policies, and decide which…
Selection CriteriaScientists must meet general requirements, expertise requirements, and requirements specific to the given study section/scientific review group. Balancing experience and diversity when developing rosters for a scientific review group is one of the most challenging tasks a…
While there is no administrative requirement that the science in a new A0 application be substantively different from any previously reviewed submission, it is not allowable to have duplicate or highly overlapping applications under review at the same time as per 2.3.7.4 Resubmission of an Unfunded…
I’ve read the definitions of Significance and Overall Impact but the two still seem rather similar. Can you provide some additional guidance?
When determining the Overall Impact score, should it equal the arithmetic mean of the scores for the scored review criteria?
Is it possible for an…